By Sindhu Sundar ( August 14, 2014, 4:57 PM EDT) -- A Missouri federal judge has rejected most claims in a woman's injury suit claiming an allegedly off-label use of Medtronic Inc.'s Infuse Bone Graft device caused her to experience severe pain and numbness, finding that her design defect and failure-to-warn claims, among others, are preempted by federal oversight. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.